A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC)
Completed · Phase 3
Conditions studied: Hepatocellular Carcinoma (HCC)
In brief
This Phase 3 study was a global, multicenter trial that randomly assigned participants to either tislelizumab or sorafenib as a first-line treatment for adults with advanced liver cancer (hepatocellular carcinoma) that could not be surgically removed. Before enrolling Japanese participants in the main Phase 3 study, a preliminary assessment of safety and tolerability (the Safety Run-In Sub-study) was conducted in Japan.
Key facts
- Study ID
- NCT03412773
- Run by
- BeiGene
- People needed
- 684
- Starts
- 2017-12-18
- Expected to finish
- 2023-12-14
- Last updated by the study team
- 2025-10-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UCLA Hematologyoncology — Los Angeles, California, United States
- Chao Family Comprehensive Cancer Center — Orange, California, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Umdnj Njms — Newark, New Jersey, United States
- Rj Zuckerberg Cancer Center — Lake Success, New York, United States
- Xcancerdayton Physician Network — Dayton, Ohio, United States
- Vanderbilt University Medical Center — Nashville, Tennessee, United States
- Ut Health San Antonio Mays Cancer Center — San Antonio, Texas, United States
- The First Affiliated Hospital of Bengbu Medical College — Bengbu, Anhui, China
- Anhui Provincial Hospital — Hefei, Anhui, China
- The First Affiliated Hospital of Anhui Medical University — Hefei, Anhui, China
- The Second Hospital of Anhui Medical University — Hefei, Anhui, China
- Cancer Hospital Chinese Academy of Medical Sciences — Beijing, Beijing Municipality, China
- Military Hospital of China — Beijing, Beijing Municipality, China
- Beijing Youan Hospital, Capital Medical University — Beijing, Beijing Municipality, China
- Beijing Cancer Hospital — Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital — Beijing, Beijing Municipality, China
- Chinese Pla General Hospital — Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Chongqing Medical University — Chongqing, Chongqing Municipality, China
- Fujian Medical University Union Hospital — Fuzhou, Fujian, China
- Fujian Cancer Hospital — Fuzhou, Fujian, China
- Sun Yat Sen Memorial Hospital, Sun Yat Sen University (North) — Guangzhou, Guangdong, China
- Guangdong Provincial Peoples Hospital — Guangzhou, Guangdong, China
- The First Affiliated Hospital, Sun Yat Sen University — Guangzhou, Guangdong, China
- Providence Medical Foundation — Fullerton, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.